Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
University of Kentucky
Merck Sharp & Dohme LLC
University of Michigan Rogel Cancer Center
Centre Antoine Lacassagne
Oslo University Hospital
Thomas Jefferson University
Dana-Farber Cancer Institute
University of Colorado, Denver
City of Hope Medical Center
Institut du Cancer de Montpellier - Val d'Aurelle
University of Pittsburgh
University of Chicago
University of Birmingham
Case Comprehensive Cancer Center
University of Chicago
Icahn School of Medicine at Mount Sinai
Charite University, Berlin, Germany
University of Chicago
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Groupe Oncologie Radiotherapie Tete et Cou
H. Lee Moffitt Cancer Center and Research Institute
CEL-SCI Corporation
Groupe Oncologie Radiotherapie Tete et Cou
The Christie NHS Foundation Trust
Bristol-Myers Squibb
UNICANCER
UNICANCER
University of Michigan Rogel Cancer Center
Radiation Therapy Oncology Group
Radiation Therapy Oncology Group
Radiation Therapy Oncology Group
Groupe Oncologie Radiotherapie Tete et Cou
Canadian Cancer Trials Group
The Netherlands Cancer Institute
University of Colorado, Denver
Ohio State University Comprehensive Cancer Center
Groupe Oncologie Radiotherapie Tete et Cou
Radiation Therapy Oncology Group
M.D. Anderson Cancer Center
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
Mayo Clinic
Shanghai Jiao Tong University School of Medicine
Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
Radiation Therapy Oncology Group
University of Miami